Medicines

  1. Aimovig (erenumab)
    Aimovig (erenumab)
    by Amgen Inc., Novartis Pharmaceuticals Corporation
    for Migraine
    €698.00
  2. Alecensa (alectinib)
    Alecensa (alectinib)
    by Roche Registration GmbH
    for Lung Cancer
    €7,350.00
  3. Aliqopa (copanlisib)
    Aliqopa (copanlisib)
    by Bayer
    for Lymphoma
    €7,657.85
  4. Alunbrig (brigatinib)
    Alunbrig (brigatinib)
    by ARIAD Pharmaceuticals, Inc.
    for Lung Cancer
    €3,657.00
  5. Austedo (deutetrabenazine)
    Austedo (deutetrabenazine)
    by Teva Pharmaceuticals
    for Huntington's Disease, Tardive Dyskenia
    €4,485.00
  6. Bavencio (avelumab)
    Bavencio (avelumab)
    by Merck Serono Europe Limited
    for Urothelial Carcinoma, Skin Cancer
    €1,259.25
  7. Beleodaq (belinostat)
    Beleodaq (belinostat)
    by Spectrum Pharmaceuticals, Inc.
    for Lymphoma
    €3,289.00
  8. Besponsa (inotuzumab ozogamicin)
    Besponsa (inotuzumab ozogamicin)
    by Pfizer Limited
    for Leukemia
    €16,502.50
  9. Blincyto (blinatumomab)
    Blincyto (blinatumomab)
    by Amgen
    for Leukemia
    €2,915.25
View as Grid List

Items 1-9 of 59

Page
per page
Set Descending Direction